Off-the-shelf NK Cells + SCT for Myeloid Malignancies

NCT05115630 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Myeloid Malignancies
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Chronic Myeloid Leukemia

Interventions

DRUG: Cyclophosphamide
DRUG: Mesna
DRUG: Filgrastim
DRUG: Melphalan
DRUG: Fludarabine phosphate
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil
DRUG: Total Body Irradiation One Dose

Sponsor

M.D. Anderson Cancer Center